West Virginia University Cancer Institute is West Virginia’s premier cancer facility with a national reputation of excellence in cancer treatment, prevention and research. The Scientific Programs within the MBRCC are organized to nurture interactions between basic, clinical and population scientists and are designed to impact on specific health disparities and populations with unique needs within our state.
Programs include Epithelial-Mesenchymal Transition Program, Breast Cancer, Osborn Hematopoietic Malignancy and Transplantation, and Allen Lung Cancer. Members in these Programs include over 100 faculty from eight schools and 33 department across campus. This interdisciplinary environment helps further cancer research by understanding the biological mechanisms and progression of cancer, translating these discoveries into therapeutic targets to treat and prevent the diseases, and engaging high risk and underserved communities to reduce the burden of cancer among West Virginians.
Researchers are supported by Shared Resources, or Core Facilities, including Animal Models and Imaging, Biospecimen Processing, Bioinformatics and Biostatistics, Flow Cytometry, Microscope Imaging, and others. In addition, the Clinical Trials Research Unit (CTRU) provides services and expertise to Members to support clinical and translational research.
The goal is to provide access for cancer patients throughout the State of West Virginia to state-of-the-art clinical trials, develop new anticancer therapies, and contribute to the clinical science of advancing therapeutics for the cancer patient.